Sandra Pérdomo

1.3k total citations
32 papers, 262 citations indexed

About

Sandra Pérdomo is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Sandra Pérdomo has authored 32 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 9 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Sandra Pérdomo's work include Cancer Genomics and Diagnostics (9 papers), Genetic factors in colorectal cancer (5 papers) and Head and Neck Cancer Studies (4 papers). Sandra Pérdomo is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Genetic factors in colorectal cancer (5 papers) and Head and Neck Cancer Studies (4 papers). Sandra Pérdomo collaborates with scholars based in Colombia, France and Spain. Sandra Pérdomo's co-authors include Paul Brennan, David Forman, Mónica S. Sierra, Irene Rodríguez‐Hernández, Ángel Santos‐Briz, Juan Luis Garcı́a, Juan Jesús Cruz, Rogelio González‐Sarmiento, Florence Le Calvez‐Kelm and Ivana Holcátová and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and PLoS ONE.

In The Last Decade

Sandra Pérdomo

24 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Pérdomo Colombia 8 106 89 74 67 54 32 262
Joanne Jang United States 8 46 0.4× 119 1.3× 46 0.6× 134 2.0× 81 1.5× 20 315
Tim Rattay United Kingdom 9 117 1.1× 76 0.9× 184 2.5× 77 1.1× 58 1.1× 26 585
S. Guihard France 10 64 0.6× 66 0.7× 125 1.7× 116 1.7× 100 1.9× 47 342
Thiago Bueno de Oliveira Brazil 10 76 0.7× 56 0.6× 107 1.4× 143 2.1× 100 1.9× 35 299
Mo‐Fa Gu China 11 51 0.5× 57 0.6× 181 2.4× 129 1.9× 105 1.9× 16 339
Graziana Ronzino Italy 6 48 0.5× 70 0.8× 15 0.2× 116 1.7× 38 0.7× 22 237
S.-B. Kim South Korea 8 58 0.5× 44 0.5× 19 0.3× 222 3.3× 83 1.5× 20 308
Evangelos Voulgaris Greece 7 94 0.9× 125 1.4× 12 0.2× 109 1.6× 27 0.5× 8 262
Wanxing Chai‐Ho United States 6 27 0.3× 66 0.7× 75 1.0× 201 3.0× 76 1.4× 24 298
Louis Bazire France 9 131 1.2× 53 0.6× 29 0.4× 123 1.8× 85 1.6× 24 344

Countries citing papers authored by Sandra Pérdomo

Since Specialization
Citations

This map shows the geographic impact of Sandra Pérdomo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Pérdomo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Pérdomo more than expected).

Fields of papers citing papers by Sandra Pérdomo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Pérdomo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Pérdomo. The network helps show where Sandra Pérdomo may publish in the future.

Co-authorship network of co-authors of Sandra Pérdomo

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Pérdomo. A scholar is included among the top collaborators of Sandra Pérdomo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Pérdomo. Sandra Pérdomo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pérdomo, Sandra, et al.. (2025). Prevention of Recurrent Urinary Tract Infection in Women: An Update. Microbiology Research. 16(3). 66–66.
2.
Pérdomo, Sandra, Socorro Aída Borges-Yáñez, Patrick Allen, et al.. (2025). The Political Determinants of Oral Health Inequalities: Lessons in Policy Development and Implementation From Six Case Studies. Community Dentistry And Oral Epidemiology. 53(5). 514–532.
3.
Pérdomo, Sandra, et al.. (2025). Quality of care in Colombian women with early-onset breast cancer in two time periods: findings from a nationwide administrative registry cohort. The Lancet Regional Health - Americas. 43. 101018–101018.
4.
Laversanne, Mathieu, et al.. (2025). Increase of early-onset colorectal cancer: a cohort effect. JNCI Journal of the National Cancer Institute.
5.
Velasco‐Herrera, Martin Del Castillo, Mathew A. Beale, Kim Wong, et al.. (2025). SPARKI: a tool for the statistical analysis of pathogen identification results. Bioinformatics. 41(11).
6.
Oliver, Javier, et al.. (2024). Methylation marks in blood DNA reveal breast cancer risk in patients fulfilling hereditary disease criteria. npj Precision Oncology. 8(1). 136–136. 4 indexed citations
7.
Acosta, Gabriela B., et al.. (2024). Mutational spectrum of breast cancer by shallow whole-genome sequencing of cfDNA and tumor gene panel analysis. PLoS ONE. 19(9). e0308176–e0308176.
8.
Penha, Ricardo Cortez Cardoso, Luis I. Terrazas, Talía Wegman-Ostrosky, et al.. (2023). Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico. Frontiers in Genetics. 14. 1094260–1094260. 4 indexed citations
9.
Casolino, Raffaella, Amber L. Johns, Mélanie Courtot, et al.. (2023). Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission. The Lancet Oncology. 24(2). 123–125. 4 indexed citations
10.
Sichero, Laura, Marta Tagliabue, Silvaneide Ferreira, et al.. (2021). Biomarkers of human papillomavirus (HPV)‐driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16INK4a status. Head & Neck. 44(1). 122–133. 4 indexed citations
11.
Pérdomo, Sandra, et al.. (2020). Analysis of the Cost-Effectiveness of Liquid Biopsy to Determine Treatment Change in Patients with Her2-Positive Advanced Breast Cancer in Colombia. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Pérdomo, Sandra, et al.. (2020). <p>Analysis of the Cost-Effectiveness of Liquid Biopsy to Determine Treatment Change in Patients with Her2-Positive Advanced Breast Cancer in Colombia</p>. ClinicoEconomics and Outcomes Research. Volume 12. 115–122. 22 indexed citations
14.
Carvalho, Ana Carolina de, Sandra Pérdomo, Cristovam Scapulatempo‐Neto, et al.. (2020). Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma. Scientific Reports. 10(1). 9970–9970. 6 indexed citations
15.
Pérdomo, Sandra, et al.. (2020). Secuenciación de nueva generación (NGS) de ADN: presente y futuro en la práctica clínica. Universitas Médica. 61(2). 4 indexed citations
16.
Pérdomo, Sandra, Devasena Anantharaman, Matthieu Foll, et al.. (2018). Genomic analysis of head and neck cancer cases from two high incidence regions. PLoS ONE. 13(1). e0191701–e0191701. 17 indexed citations
17.
Oliver, Javier, et al.. (2017). Cancer Genomic Resources and Present Needs in the Latin American Region. Public Health Genomics. 20(3). 194–201. 14 indexed citations
18.
Pérdomo, Sandra, et al.. (2016). Head and neck cancer burden and preventive measures in Central and South America. Cancer Epidemiology. 44. S43–S52. 58 indexed citations
19.
Núñez, Mercedes, et al.. (2010). The G1359A-CNR1 gene polymorphism is associated to glioma in Spanish patients. Clinical & Translational Oncology. 12(12). 825–828. 1 indexed citations
20.
Pollán, Marina, Beatriz Pérez‐Gómez, Núria Aragonés, et al.. (2007). Situación epidemiológica del cáncer de mama en España. SHILAP Revista de lepidopterología. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026